The ‘Global Athlete’s Foot Treatment Market Growth, Size, Share, Report and Forecast 2023-2031’ by Expert Market Research gives an extensive outlook of the global athlete’s foot treatment market, assessing the market on the basis of its segments like drug class, application mode, distribution channels, and major regions.
The report studies the latest updates in the market, along with their impact across the market. It also analysis the market demand, together with its price and demand indicators. The report also tracks the market on the bases of SWOT and Porter’s Five Forces Models.
Athlete’s Foot Treatment Market Share, Size, Price, Growth, Trends, Industry Report, Key Player, Major Segments and Forecast
The key highlights of the report include:
Market Overview (2016-2031)
- Historical Market Size (2022): USD 8.8 billion
- Forecast CAGR (2023-2031): 6.70%
- Forecast Market Size (2031): USD 15.7 billion
Increasing incidences of athlete’s foot fungal infections have escalated the need for treatments in the recent years, driving the growth of the global athlete’s foot treatment market. The growing accessibility of over-the-counter drugs, novel product launches, and low-cost therapeutic strategies are also expected to bolster the growth of the market for athlete’s foot treatments. The rising number of cases coupled with affordable treatment options and doctor consultations are also expected to bolster the athlete’s foot treatment market growth.
Get a Free Sample Report with Table of Contents@ https://www.expertmarketresearch.com/reports/athletes-foot-treatment-market/requestsample
Prescription of mode of treatment is dependent on factors such as severity, diagnostic test assessment, and the affected area. Availability of drugs with different application modes such as sprays, powders, creams, liquids, and tablets have made the treatment process more convenient for patients and have further contributed towards the growth of the market.
Home remedies and alternative therapies have shown promising results in management of athlete’s foot. Anti-fungal medicines are available in a wide range, including butenafine, terbinafine, miconazole, clotrimazole and tolnaftate. The wide selection of treatment options enable healthcare personnel and patients to choose the combination that works best for them, further contributing to the athlete’s foot treatment market growth. Ongoing developmental activities and extensive research will likely expedite novel product discovery. Novel targeted therapies are expected to garner the attention of the key market player and thus fuel the growth of the market during the forecast period.
Athlete’s Foot Treatment Industry Definition and Major Segments
Athlete’s foot often known as tinea pedis is a fungal infection which typically starts between the person’s toes and commonly happens when feet become highly sweaty while confined in shoes. The condition is caused by the tinea fungus and is known as athlete’s foot due to its high prevalence in athletes. Treatment generally involves application of topical medications which help relieve the symptoms and clean up the infection.
Read Full Report with Table of Contents@ https://www.expertmarketresearch.com/reports/athletes-foot-treatment-market
On the basis of drug class, the market is divided into:
Based on application mode, the market is classified into:
On the basis of distribution channel, the market is segregated into:
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
Based on region, the market is categorised into:
- North America
- Asia Pacific
- Latin America
- Middle East and Africa
Athlete’s Foot Treatment Market Trends
The key trends in the global athlete’s foot treatment market include the growing research and development activities by leading pharmaceutical companies with the aim of developing cost efficient and fast acting treatments with minimal side effects. Increase in awareness about the benefits of using athlete’s foot medications is also expected to favour the growth of the market.
The thriving natural and organic treatment sector, owing to increase in disposable incomes and awareness of the benefits of using natural treatments, is another crucial trend supporting the growth of athlete’s foot treatment market. Increasing adoption and promotion of these drugs by sportspersons and athletes for quick recovery and improved performance is also contributing to the market growth. Sprays are sizable contributors to the increase in the market for athlete’s foot treatment globally, due to their easy application and convenient packaging.
In regional terms, North America accounts for a significant share of the global market, for athlete’s foot treatment owing to the growing cases of athlete’s foot infections, availability of improved healthcare facilities and rising awareness. Meanwhile, the Asia Pacific is projected to witness rapid growth during the forecast period due to increase in healthcare sector development, major investments from key players, and increasing awareness about the condition.
Key Market Players
The major players in the global athlete’s foot treatment market report are Cipla Limited, Johnson & Johnson, GSK plc, Mylan N.V., Novartis AG, Pfizer Inc., Merck & Co., Inc., Sanofi S.A., Bayer AG, Enzon Pharmaceuticals, Inc and Abbott Laboratories. The report covers the market shares, capacities, plant turnarounds, expansions, investments and mergers and acquisitions, among other latest developments of these market players.
Expert Market Research (EMR) is leading market research company with clients across the globe. Through comprehensive data collection and skillful analysis and interpretation of data, the company offers its clients extensive, latest, and actionable market intelligence which enables them to make informed and intelligent decisions and strengthen their position in the market. The clientele ranges from Fortune 1000 companies to small and medium scale enterprises.
EMR customises syndicated reports according to clients’ requirements and expectations. The company is active across over 15 prominent industry domains, including food and beverages, chemicals and materials, technology and media, consumer goods, packaging, agriculture, healthcare and pharmaceuticals, among others.
Over 3000 EMR consultants and more than 100 analysts work very hard to ensure that clients get only the most updated, relevant, accurate and actionable industry intelligence so that they may formulate informed, effective and intelligent business strategies and ensure their leadership in the market.
Company Name: Claight Corporation
Contact Person: Steven Luke, Corporate Sales Specialist – U.S.A.
Toll Free Number: +1-415-325-5166 | +44-702-402-5790
Address: 30 North Gould Street, Sheridan, WY 82801, USA